Диссертация (1174363), страница 31
Текст из файла (страница 31)
Sofuni, H. Maguchi, T. Itoi, A.Katanuma, H.Hisai, T.Niido,M.Toyota,T.Fujii,Y.Harada,T.Takada//Clin. Gastroenterol. Hepatol. - 2007. – N 5. – P. 1339-1346.250.Sotoudehmanesh, R. A randomized trial of rectal indomethacin and sublingual nitrates to pre-vent post-ERCP pancreatitis/ R. Sotoudehmanesh, M.A. Eloubeidi, A.A. Asgari, M. Farsinejad,M. Khatibian// Am.
J. Gastroenterol. - 2014. - V 109(6). - P. 903-9.134251.Sotoudehmanesh, R. Indomethacin may reduce the incidence and severity of post-ERCP acutepancreatitis/ R. Sotoudehmanesh, M. Khatiban, S. Kolahdoozan, S. Ainechi, R. Malboosbaf, M.Nouraie/ Am. J. Gastroenterology. – 2007. – N 102. – P. 978.252.Sternlieb, J.M. A multicenter, randomized, controlled trial to evaluate the effect of prophylacticoctreotide on ERCP- induced pancreatitis/ J.M. Sternlieb, C.A. Aronchick, J.N.
Retig, M. Dabezies, F.Saunders, E. Goosenberg, A. Infantolino, S. Ionna, G. Maislin, S.H. Wright// Am. J. Gastroenterol. –1992. - V 87 (11). - P. 1561 – 1566.253.Swan, M.P. Needle knife sphincterotomy does not increase the risk of pancreatitis in patientswith difficult biliary cannulation/ M.P. Swan, S. Alexander, A.
Moss, S. J. Williams, D. Ruppin, R.Hope, M. J. Bourke// Clin. Gastroenterol. Hepatol. – 2013. – N 11. – P. 430 – 436.254.Tarnasky, P.R. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results,techniques, and indications/ P.R. Tarnasky// JOP. - 2003. – V 4(1). – P. 58-67.255.myTarnasky,P.R.Pancreaticstentingpreventspancreatitisafterbiliaryin patients with sphincter of Oddi dysfunction/ P.R. Tarnasky, Y.Y.
Palesch , J.T. Cunning-ham, P.D. Mauldin, P.B. Cotton, R.H. Hawes// Gastroenterology. - 1998. – N 115. – P. 1518-24.256.Testoni, P. Pharmacological prevention of post-ERCP pancreatitis: The facts and the fiction/P. Testoni// JOP. J. Pancreas (Online). – 2004. – N 5. – P. 171–178.257.Testoni, P.A. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: anever-ending story/ P.A. Testoni// Gastrointest Endosc.
– 2006. – N 64. – P. 732–734.258.Testoni, P.A. Simple measures to prevent post- ERCP pancreatitis?/ P.A. Testoni// Gut. - 2008.– V 57 (9). – P. 1197–1198.259.Testoni, P.A. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis:results of a multicenter, randomized, controlled trial/ P.A. Testoni, F. Bagnolo, A. Andriulli,G.Bernasconi, S. Crotta, F. Lella, A. Zambelli// Aliment.
Pharmacol. Ther. - 2001. - V 15 (7). - P.965 – 972.260.Thomopoulos, K.C. Twenty-four hour prophylaxis with increased dosage of octreotide reducesthe incidence of post-ERCP pancreatitis/ K.C. Thomopoulos, N.A. Pagoni, K.A. Vagenas, V.G.Margaritis, G.I. Theocharis, V.N. Nikolopoulou// Gastrointest. Endosc. – 2006.
– V 64 (5). – P. 726 –731.261.Trap, R. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospectiveseries of claims to insurance covering public hospitals/ R, Trap, S. Adamsen, O. Hart-Hansen, M.Henriksen// Endoscopy. – 1999.
– V 31(2). – P.125-30.135262.Truog,R.D.RefusalofhydrationandnutritionIrrelevanceofthe“artificial” vs “natural” distinction/ R.D. Truog, T.I. Cochrane// Arch. Intern. Med. – 2005. - V165(22). – P. 2574-2576.263.Tse, F. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis/ F. Tse, Y. Yuan, M. Bukhari,G.I. Leontiadis, P. Moayyedi, A.
Barkun [Electronic Resource] // Cochrane Database Syst Rev. –2016.-V16(5).–Режимдоступа:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010571.pub2/full (дата обращения:24.06.2016).264.Tsuchiya,T. Temporarypancreaticstenttopreventpostendoscopicretrogradecholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial/ T.Tsuchiya, T. Itoi , A. Sofuni , F. Itokawa, T.
Kurihara, K. Ishii, S. Tsuji, T. Kawai, F. Moriyasu// J.Hepatobiliary Pancreat. Surg. - 2007. –N 14. – P. 302-307.265.Uhl, W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acutepancreatitis/ W. Uhl, M.W. Büchler, P. Malfertheiner, H.G. Beger, G. Adler, W. Gaus// Gut. – 1999. V 45(1). – P.
97-104.266.Van Geenen, E.J. Lack of consensus on the role of endoscopic retrograde cholangiography inacute biliary pancreatitis in published meta-analyses and guidelines: a systematic review/ E.J. VanGeenen, H.C. Van Santvoort, M.G. Besselink, D.L. Van der Peet, K.J.
Van Erpecum, P. Fockens, C.J.Mulder, M.J. Bruno// Pancreas. - 2013. – N 42. – P. 774-780.267.Vandervoort, J. Risk factors for complications after performance of ERCP/ Vandervoort J,R.M. Soetikno, T.C. Tham, R.C. Wong, A.P. Ferrari, H. Montes, et al.// Gastrointest Endosc. – 2002. N 56. – P. 652–656.268.Wan, J. How to select patients and timing for rectal indomethacin to prevent post-ERCPpancreatitis: a systematic review and meta-analysis/ J. Wan, Y. Ren, Z. Zhu, L. Xia, N. Lu// BMCGastroenterol. – 2017. – V 17(1).
– P. 43.269.Wang, P. Risk factors for ERCP-related complications: a prospective multicenter study/ P.Wang, Z.-S. Li, F. Liu, N.H. Lu , Z.N. Fan, Q. Huang, X. Zhang, L.P. He, W.S. Sun, Q. Zhao, R.H.Shi, Z.B. Tian, Y.Q. Li, W. Li, F.C. Zhi// Am. J.
Gastroenterol. - 2009. - N 104. - P. 31– 40.270.Wang, Z.K. Is prophylactic somatostatin effective to prevent post-endoscopic retrogradecholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilottrial/ Z.K. Wang, Y.S. Yang, F.C. Cai, Y.H. Wang, X.L. Shi, C. Ding, W. Li// Chin. Med. J (Engl). –2013. – V 126(13). –P. 2403-8.136271.Weinberg,B.M.Endoscopic balloonsphincter dilation (sphincteroplasty)versussphincterotomy for common bile duct stones [Electronic Resource] / B. M. Weinberg, W. Shindy, S.Lo//CochraneDat.Syst.Rev.–2006.–V18(4).–Режимдоступа:https://www.ncbi.nlm.nih.gov/pubmed/17054222 (дата обращения: 26.12.2015).272.Whitcomb,D.C.Acute pancreatitis:molecular biologyupdate/D.C.Whitcomb//J.
Gastrointest. Surg. - 2003. – N 7. – P. 940–942.273.Williams, E.J. Risk factors for complication following ERCP; results of a large-scale,prospective multicenter study/ E.J. Williams, S. Taylor, P. Fairclough, A. Hamlyn, R.F. Logan, D.Martin, S.A. Riley, P. Veitch, M.L. Wilkinson, P.R. Williamson, M. Lombard// Endoscopy. – 2007. N 39. – P. 793–9.274.Woods, K.E. Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review/ K.E. Woods, F.F. Willingham// World J.
Gastrointest. Endosc. – 2010. – V 2 (5). – P.165–178.275.Xiong, G.S. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrogradecholangiopancreatography pancreatitis/ G.S. Xiong, S.M. Wu, X.W. Zhang, Z.Z. Ge// Braz. J.Med. Biol. Res. – 2006. – V 39. – P. 85-90.276.Yang, J. Therapeutic efficacy of endoscopic retrograde c holangiopancreatography amongpregnant women with severe acute biliary pancreatitis/ J. Yang, X. Zhang, X.J.Zhang//Laparoendosc.
Adv. Surg. Tech. A. – 2013. – V 23(5). – P. 437-40.277.Yang, D. Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitisprophylaxis: Is it the magic bullet?/ D. Yang, P. V. Draganov//World J. Gastroenterol. - 2012. – V18(31). – P. 4082-5.278.Yasuda, K. The handbook of endoscopic ultrasonography in digestive tract/ K. Yasuda//Blackwell Science Japan K.K. - 2000. - P. 152.279.Yu, G. Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis: A Meta-analysis ofProspective, Randomized, Controlled Trials/ G.
Yu, S. Li, R. Wan, X. Wang, G. Hu// Pancreas. –2015. - V 44(4). – P. 561-9280.Yu, W. Early percutaneous transhepatic gallbladder drainage compared with endoscopicretrograde cholangiopancreatography and papillotomy treatment for severe gallstone associated acutepancreatitis/ W. Yu, W. Li, Z. Wang, X. Ye, N. Li, J.
Li// Postgrad Med. J. – 2007. – V. 83(977). – P.187–191.281.Yuhara,H. J.Pharmacologicprophylaxisofpost-endoscopicretrogradecholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis/ H.137Yuhara, M. Ogawa, Y. Kawaguchi, M. Igarashi, T. Shimosegawa, T. Mine// Gastroenterol. – 2014. –V 49(3). – P. 388-99.282.Zhang, Y.